Literature DB >> 17151106

Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator.

Peter Vanlandschoot, Freya Van Houtte, Benedikte Serruys, Geert Leroux-Roels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17151106      PMCID： PMC1865924          DOI： 10.1128/JVI.02507-06

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  8 in total

Review 1.  The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure.

Authors:  Peter Vanlandschoot; Tinghua Cao; Geert Leroux-Roels
Journal:  Antiviral Res       Date:  2003-10       Impact factor: 5.970

2.  The role of heparan sulfate and TLR2 in cytokine induction by hepatitis B virus capsids.

Authors:  Peter Vanlandschoot; Geert Leroux-Roels
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

3.  Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.

Authors:  T Cao; U Lazdina; I Desombere; P Vanlandschoot; D R Milich; M Sällberg; G Leroux-Roels
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked.

Authors:  Peter Vanlandschoot; Freya Van Houtte; Peter Ulrichts; Jan Tavernier; Geert Leroux-Roels
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

5.  Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.

Authors:  Isabelle Béatrice Bekeredjian-Ding; Isabelle Béatrice Berkeredjian-Ding; Moritz Wagner; Veit Hornung; Thomas Giese; Max Schnurr; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

6.  Role of B cells in antigen presentation of the hepatitis B core.

Authors:  D R Milich; M Chen; F Schödel; D L Peterson; J E Jones; J L Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis.

Authors:  S Stahl; P MacKay; M Magazin; S A Bruce; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  "Dirty little secrets"--endotoxin contamination of recombinant proteins.

Authors:  Sonia J Wakelin; Ian Sabroe; Christopher D Gregory; Ian R Poxton; John L R Forsythe; O James Garden; Sarah E M Howie
Journal:  Immunol Lett       Date:  2006-05-11       Impact factor: 3.685
  8 in total
  8 in total

1.  Interaction of the hepatitis B core antigen and the innate immune system.

Authors:  Byung O Lee; Amy Tucker; Lars Frelin; Matti Sallberg; Joyce Jones; Cory Peters; Janice Hughes; David Whitacre; Bryan Darsow; Darrell L Peterson; David R Milich
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

2.  Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.

Authors:  Katleen Broos; Michiel E Janssens; Ine De Goeyse; Peter Vanlandschoot; Geert Leroux-Roels; Dirk Geysen; Yves Guisez
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

Review 3.  Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.

Authors:  Zhiyong Ma; Ejuan Zhang; Dongliang Yang; Mengji Lu
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

Review 4.  Use of hepadnavirus core proteins as vaccine platforms.

Authors:  David C Whitacre; Byung O Lee; David R Milich
Journal:  Expert Rev Vaccines       Date:  2009-11       Impact factor: 5.217

Review 5.  Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.

Authors:  Suzanne Faure-Dupuy; Julie Lucifora; David Durantel
Journal:  Viruses       Date:  2017-04-28       Impact factor: 5.048

Review 6.  Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.

Authors:  Zhiyong Ma; Qian Cao; Yong Xiong; Ejuan Zhang; Mengji Lu
Journal:  Vaccines (Basel)       Date:  2018-01-16

Review 7.  Acute-on-Chronic Liver Failure From Chronic-Hepatitis-B, Who Is the Behind Scenes.

Authors:  Qian Li; Jun Wang; Mengji Lu; Yuanwang Qiu; Hongzhou Lu
Journal:  Front Microbiol       Date:  2020-12-07       Impact factor: 5.640

8.  Hepatitis B virus particles activate B cells through the TLR2-MyD88-mTOR axis.

Authors:  Qian Li; Jun Wang; Heba Islam; Carsten Kirschning; Hongzhou Lu; Daniel Hoffmann; Ulf Dittmer; Mengji Lu
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.